| N (%) | OR (95% CI) | AOR (95% CI) | p-value |
---|---|---|---|---|
Ethnicity | Â | Â | Â | Â |
   White | 309 (23) | 1.0 | 1.0 |  |
   Black | 793 (59) | 0.41 (0.31, 0.53) | 0.67 (0.49, 0.91) | 0.0107 |
   Other | 248 (18) | 0.40 (0.28, 0.57) | 0.89 (0.60, 1.32) | 0.5490 |
Geographic area | Â | Â | Â | Â |
   Europe | 372 (28) | 1.0 | 1.0 |  |
   USA | 978 (72) | 0.18 (0.14, 0.23) | 0.18 (0.14, 0.24) | 0.0001 |
Antenatal ART | Â | Â | Â | Â |
   None/monotherapy | 309 (23) | 1.0 | 1.0 |  |
   Dual therapy | 474 (35) | 0.51 (0.38, 0.69) | 0.57 (0.41, 0.78) | 0.0006 |
   HAART | 567 (42) | 0.54 (0.41, 0.72) | 0.70 (0.52, 0.96) | 0.0263 |
CD4 count (entry) | Â | Â | Â | Â |
   < 400 cells per ml | 586 (43) | 1.0 | 1.0 |  |
   ≥400 cells per ml | 764 (57) | 1.06 (0.84, 1.33) | 1.08 (0.84, 1.39) | 0.5371 |
CD4 count (delivery) | Â | Â | Â | Â |
   < 400 cells per ml | 543 (40) | 1.0 | 1.0 |  |
   ≥400 cells per ml | 807 (60) | 1.04 (0.83, 1.31) | 1.10 (0.86, 1.42) | 0.4486 |
Viral load (entry) | Â | Â | Â | Â |
   Undetectable | 570 (44) | 1.00 | 1.0 |  |
   Detectable | 740 (56) | 0.97 (0.77, 1.23) | 0.83 (0.65, 1.07) | 0.1571 |
Viral load (delivery) | Â | Â | Â | Â |
   Undetectable | 626 (53) | 1.0 | 1.0 |  |
   Detectable | 555 (47) | 0.82 (0.64, 1.05) | 0.90 (0.69, 1.17) | 0.4308 |